ロード中...
Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection
To realize the full potential of cancer immunotherapy, the latest generation immunotherapeutics are designed to harness the potent tumor-killing capacity of T cells. Thus, to mobilize T cells, new optimized bispecific antibody (BsAb) designs, enabling efficient polyclonal redirection of cytotoxic ac...
保存先:
| 出版年: | Curr Opin Immunol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4884546/ https://ncbi.nlm.nih.gov/pubmed/26963133 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2016.02.006 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|